Task X11: Product Development Plans and Feasibility Assessments
$106,884N01FY2015AINIH
Advanced Bioscience Laboratories, Inc., Kensington MD
Investigators
Abstract
The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services; this task order is focused on providing product development plans and feasibility assessments.
View original record on NIH RePORTER →